World’s most expensive drug, costs ₹18 crore per dose

The one-off gene therapy treats SMA, a rare and often fatal genetic disease that causes paralysis, muscle weakness and progressive loss of movement.

168
Approved
Picture: Pixabay

Last Updated on March 11, 2021 by The Health Master

Zolgensma which has a reported list price of £1.79 million( ₹18 crore) per dose is labelled the most expensive drug in the world. Zolgensma was approved by the NHS England on Monday to treat babies with a rare fatal genetic disorder.

Zolgensma, a life-saving drug, can enable mobility in babies and young children suffering from a rare genetic condition. Zolgensma is an adeno-associated virus vector-based gene therapy indicated for the treatment of pediatric patient less than 2 years of age with spinal muscular atrophy (SMA).

Zolgensma – most expensive drug in the world

The one-off gene therapy treats SMA, a rare and often fatal genetic disease that causes paralysis, muscle weakness and progressive loss of movement.

Babies born with severe type 1 SMA – the most common form of the condition – have a life expectancy of just two years.

In studies, Zolgensma, manufactured by Novartis Gene Therapies, has helped babies to reach milestones such as breathe without a ventilator, sit up on their own and crawl and walk after a single infusion treatment.

The latest data suggested that Zolgensma can provide rapid and sustained improvement in motor function for young children with type 1 SMA and prolong their lives.


Also read:

NATCO gets USFDA nod for Breast Cancer treatment drug

Kite gets USFDA nod for drug to treat Follicular Lymphoma

Shilpa Medicare gets USFDA tentative nod for drug for Arthritis

Aleor Dermaceuticals gets USFDA nod for Testosterone Gel

Unichem gets USFDA nod for Guanfacine Tablets

Cipla gets US FDA approval for generic drug for Migraine

Telegram
WhatsApp
Facebook
LinkedIn
Google-news

Enter your email address:

Delivered by FeedBurner